Ocimum Launches Special Tuberculosis Day Awareness Campaign

Hyderabad, India (PressExposure) March 27, 2009 -- As a part of the Tuberculosis Day awareness campaign, Ocimum Biosolutions launched a special campaign to spearhead the use of its tuberculosis typing kits. According to WHO, one-third of the world's population is currently infected with the TB bacillus. Moreover, 5-10% of people who are infected with TB bacilli (but who are not infected with HIV) become sick or infectious at some time during their life.

Ocimum Biosolutions offers a kit that can be simultaneously used for detection as well as typing of the Mycobacterium tuberculosis complex. This is a PCR-based method, which depends on the amplification of a highly polymorphic Direct Repeat (DR) locus in M. tuberculosis genome. This technique is highly useful for clinical samples as it can detect the causative bacteria and is capable of providing epidemiological information on strain identities. This technique has high specificity and sensitivity with clinical samples. This kit contains one membrane, positive control 1(M. tuberculosis strainH37Rv), positive control 2 (M. bovis BCG P3), Primer DRa (biotinylated) and Primer Drb.

As a part of Tuberculosis Day awareness drive, Ocimum Biosolutions calls for collaborations with researchers, scientists and organizations working to combat the global challenges in tuberculosis.

For further information, contact us at europe@ocimumbio.com.


For media-related queries, please contact: Ms. Nazia Sultana +91 40 66627200 pr@ocimumbio.com

About Ocimum Biosolutions

Ocimum Biosolutions is a leading integrated genomics company providing comprehensive genomic reference databases, life science lab information management solutions, GLP-compliant microarray services and essential research consumables. Over 2/3rd of the top 25 pharma companies, leading research institutes and emerging biotech companies worldwide have chosen us as their preferred outsourcing partner and utilize our expertise for understanding underlying mechanisms of diseases, discovery and prioritization of gene targets and biomarkers.

For more information, please visit http:/www.ocimumbio.com

Press Release Source: http://PressExposure.com/PR/Ocimum_Biosolutions.html

Press Release Submitted On: March 26, 2009 at 1:43 am
This article has been viewed 25651 time(s).